InvestorsHub Logo
Followers 16
Posts 1145
Boards Moderated 0
Alias Born 03/12/2010

Re: None

Monday, 02/06/2017 10:06:54 AM

Monday, February 06, 2017 10:06:54 AM

Post# of 63
Immunovaccine's Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial in Ovarian Cancer in Combination With Approved Anti-PD-1 Drug


http://www.marketwired.com/press-release/immunovaccines-lead-immuno-oncology-candidate-enter-investigator-sponsored-phase-2-clinical-tsx-imv-2193529.htm
https://www.google.com/finance?q=TSE%3AIMV&ei=ro-YWMDJJo-UUp_hivAB